Results 1 to 10 of about 7,440,039 (299)
Exposing drug industry funding of UK patient organisations.
BMJ, 2019 Drug company payment disclosures have limited transparency, but Piotr Ozieranski and colleagues find that they are increasing in value and are targeted at select patient ...
Ozieranski P, Rickard E, Mulinari S.
europepmc +3 more sources
Drug Addiction in the Industries [PDF]
The Journal of Nervous and Mental Disease, 1922 n ...
Blair,, Thos, S.
openaire +5 more sources
Illegal Drug Usage and Industry [PDF]
American Association of Industrial Nurses Journal, 1967 Frank E. Sweeney
openaire +4 more sources
Medical Representatives’ User Acceptance of Remote e-Detailing Technology: A Moderated Mediation Analysis of Technology Acceptance Model [PDF]
Healthcare Informatics Research, 2022 Objectives E-detailing methods have steadily evolved toward more contactless and interactive channels, which have received considerable attention during the coronavirus disease 2019 (COVID-19) crisis.
Hyun Woo Kim, Hyejung Chang
doaj +1 more source
Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study [PDF]
British medical journal, 2003 Chris Watkins
openalex +2 more sources
Pharmaceutical industry before COVID-19 [PDF]
Farmacja Polska, 2020 The 2019 CPhI Annual Report describing rankings, innovations and key trends in pharma industry is summarized. Pharmaceutical markets were assessed based on an the following indicators: growth potential, API manufacturing, innovation, competitiveness and ...
Krzysztof Woyna-Orlewicz +1 more
doaj +1 more source
Medical Representatives' Intention to Use Information Technology in Pharmaceutical Marketing [PDF]
Healthcare Informatics Research, 2016 ObjectivesElectronic detailing (e-detailing), the use of electronic devices to facilitate sales presentations to physicians, has been adopted and expanded in the pharmaceutical industry.
Eun-Seon Kwak, Hyejung Chang
doaj +1 more source
BMJ, 2008 The Royal College of Physicians is looking at relations between doctors and the drug industry and wants to hear from you (doi: 10.1136/bmj.39428.617431.DB). In case you need them, here are some pointers from this week’s BMJ . Firstly, should we fear for the integrity of medical research because clinical trials are overwhelmingly funded by industry ...
europepmc +4 more sources
Microbial Cell Factories, 2022 Background Acarbose, as an alpha-glucosidase inhibitor, is widely used clinically to treat type II diabetes. In its industrial production, Actinoplanes sp. SE50/110 is used as the production strain.
Zhenxin Li +6 more
doaj +1 more source